Letter to the editorPartial improvement of solar urticaria after omalizumab
References (10)
- et al.
Solar urticaria
J Am Acad Dermatol
(2008) - et al.
Pathogenesis and classification of solar urticaria: a new concept
J Am Acad Dermatol
(1989) - et al.
Immunological methods for quantifying free and total serum IgE levels in allergy patients receiving omalizumab (Xolair) therapy
J Immunol Meth
(2005) Accuracy of Food and Drug Administration-cleared IgE antibody assays in the presence of anti-IgE (omalizumab)
J Allergy Clin Immunol
(2006)- et al.
Immunological and biophysical studies in solar urticaria
J Invest Dermatol
(1963)
There are more references available in the full text version of this article.
Cited by (56)
Omalizumab treatment in patients with chronic inducible urticaria: A systematic review of published evidence
2018, Journal of Allergy and Clinical ImmunologyCitation Excerpt :The advanced search option was used with the terms “omalizumab” AND, for example, “cold urticaria” to encompass results from all fields. This was complemented by any additional published or in press evidence known to us at the time of publication (Table II).19,20,36-76 All publications have been included, regardless of whether the results were positive or negative, to present a fair and unbiased account of the available published evidence.
Response to Omalizumab in Solar Urticaria: Report of 3 Cases
2017, Actas Dermo-SifiliograficasOmalizumab in the Treatment of Chronic Inducible Urticaria
2017, Actas Dermo-SifiliograficasBiologics in Chronic Urticaria
2017, Immunology and Allergy Clinics of North AmericaEffectiveness of omalizumab in severe solar urticaria
2016, Annals of Allergy, Asthma and ImmunologyOmalizumab in patients with severe and refractory solar urticaria: A phase II multicentric study
2016, Journal of the American Academy of Dermatology
The opinions or assertions herein are the private views of the authors and are not to be construed as reflecting the views of the Department of the Army or the Department of Defense.
Disclosure of potential conflict of interest: The authors have declared that they have no conflict of interest.
Copyright © 2010 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.